Dental and Medical Problems

Dent Med Probl
Journal Impact Factor (JIF 2024) – 3.9
Journal Citation Indicator (JCI 2024) - 1.36
Scopus CiteScore (2024) – 5.0 (CiteScore Tracker – 5.8)
Index Copernicus Value (ICV 2024) – 178.25
MNiSW – 70 pts
ISSN 1644-387X (print)
ISSN 2300-9020 (online)
Periodicity – bimonthly


 

Download original text (EN)

Dental and Medical Problems

2026, vol. 63, nr 2, March-April, p. 441–454

doi: 10.17219/dmp/186946

Publication type: original article

Language: English

License: Creative Commons Attribution 3.0 Unported (CC BY 3.0)

Download citation:

  • BIBTEX (JabRef, Mendeley)
  • RIS (Papers, Reference Manager, RefWorks, Zotero)

Cite as:


Moawad AA, Abo Baker SH. Effect of chia seeds (Salvia hispanica L.) on the regeneration of salivary glands in a streptozotocin (STZ)-induced diabetic rat model. Dent Med Probl. 2026;63(2):441–454. doi:10.17219/dmp/186946

Effect of chia seeds (Salvia hispanica L.) on the regeneration of salivary glands in a streptozotocin (STZ)-induced diabetic rat model

Amira Ahmed Moawad1,2,D,E,F, Sally Hassan Abo Baker2,3,A,B,C

1 Department of Maxillofacial Surgery and Diagnostic Science, College of Dentistry, Majmaah University, Al Majmaah, Saudi Arabia

2 Department of Oral Biology, Faculty of Dentistry, Mansoura University, Egypt

3 Department of Basic Dental and Medical Sciences, Faculty of Dentistry, University of Ha’il, Saudi Arabia

Graphical abstract


Graphical abstracts

Highlights


  • Diabetes causes severe structural damage in parotid and mandibular glands of the rats through oxidative DNA damage.
  • Chia seed supplementation effectively attenuates these alterations, demonstrating pronounced antioxidant activity against diabetes-induced oxidative stress.
  • The findings support the potential use of chia seeds as a dietary adjunct for improving salivary gland histology and function in diabetic patients.
  • Further studies are required to determine optimal dosage, long-term safety and the specific bioactive compounds responsible for the observed protective effects.

Abstract

Background. Diabetes mellitus (DM) is a complex condition, with salivary gland malfunction being one of its complications. The management of the disease presents numerous side effects. Consequently, botanical products have been proposed as a promising alternative for the development of safe and effective treatments.

Objectives. The aim of the study was to investigate the antioxidant activity of chia seeds (Salvia hispanica L.) as a potential therapeutic tool for alleviating the deleterious effects of DM in albino rats.

Material and methods. The study sample comprised 66 male albino rats. Group I (= 6) received a saline solution, group II (n = 30) was subjected to diabetic induction via a single intraperitoneal injection of streptozotocin (STZ), and group III (n = 30) was subjected to diabetic induction and treated with 250 mg/kg/day of powdered chia seeds for 2 weeks prior to the administration of STZ and until the end of the study. The rats were euthanized 45 days after the induction of DM. The parotid and mandibular mucosal glands were extracted and prepared for histological (hematoxylin and eosin (H&E)), immunohistochemical (vascular endothelial growth factor (VEGF)) and comet assay analyses.

Results. Marked degenerative changes were evident in the acini and duct architecture of the parotid and mandibular mucosal glands in group II. These findings were confirmed histologically, immunohistochemically and via the comet assay. In contrast, in group III, treatment with chia seeds resulted in the regeneration of salivary gland tissues.

Conclusions. Chia seeds demonstrated antioxidant properties against DM-induced salivary gland dysfunction in albino rats.

Keywords: diabetes mellitus, regeneration, Salvia hispanica L., salivary glands, antioxidant properties

Introduction

Diabetes mellitus (DM) is a metabolic condition characterized by high blood glucose levels and disruption of carbohydrate, lipid and protein metabolism.1 It is a disorder of the endocrine system in which a decrease in the production of insulin results in elevated blood glucose levels.2 In addition, uncontrolled DM results in end organ damage affecting the genitourinary, cardiovascular and neurological systems.3

Salivary glands are a set of major and minor glands that secrete saliva into the oral cavity through the duct system. Rats have multiple minor glands and 3 pairs of major salivary glands, namely the parotid, submandibular and sublingual glands.4

The production of saliva is necessary to maintain the equilibrium of the oral cavity and overall health.5 In diabetic conditions, salivary glands are exposed to deleterious effects, leading to reduced saliva production, destruction of the periodontium, salivary hypofunction, and oral mucous membrane injury.6 An association has been established between complications of diabetes and salivary malfunction. Xerostomia (dry mouth due to a deficient amount of saliva) and polydipsia (pathological thirst) are frequently observed in diabetic subjects as a result of diminished salivary secretion.7 Many authors have stated that the decreased salivary flow rate in diabetic patients is caused by increased urination, which leads to a reduction in extracellular fluid volume, necessary for saliva production by the salivary glands.8

Recent studies have demonstrated that hyperglycemia occurs as a consequence of DM. The condition produces oxidative and cellular impairments, which in turn negatively affect the normal structure of organs and tissues.9 Constant elevation of blood sugar levels leads to long-term oxidative stress that triggers the excessive production of reactive oxygen species (ROS). The occurrence of diabetic complications and their progression are mediated by ROS.10 Reactive oxygen species are highly reactive chemical molecules that, when significantly elevated under stressful conditions, lead to profound damage to cellular structures, especially when antioxidant systems are compromised.11

Various oxidative stress markers, such as 8-hydroxy-2’-deoxyguanosine (8-OHdG), protein carbonyl (PC), 4-hydroxynonenal–protein adduct (4-HNE), oxidized and/or malondialdehyde (MDA)-modified low-density lipoprotein (LDL) cholesterol (oxy-LDL/MDA-LDL) and 8-isoprostanes (8-isoP), have been investigated in streptozotocin (STZ)-induced DM rats to assess oxidative damage in the salivary glands. The results indicated that the 3 major salivary glands are subjected to increased oxidative stress regardless of disease duration. However, the parotid glands showed the greatest extent and diversity of oxidative injury.11

At present, salivary gland dysfunction is treated by stimulation of salivary secretion, either through oral receptors using ascorbic acid, by stimulating mastication (e.g., chewing gum), or by pharmacological stimulation using pilocarpine. Nevertheless, all of these remedies cause several complications and provide only short-time relief; therefore, effective long-term therapy is still needed.12

Another treatment approach for DM relies on oral hypoglycemic agents or insulin. Besides being costly, these drugs cause several side effects, such as decreased blood sodium levels, jaundice, nausea, headaches, vomiting, and increased body weight.13 In low-, middle- and high-income countries, populations often rely on botanical products for health maintenance, because they are frequently considered a safe and effective approach to managing chronic diseases. Lately, a variety of botanical products have been accepted for the treatment of DM and its complications.14

Over the last few years, medicinal plants have emerged as promising therapeutic agents with hypoglycemic effects for DM treatment.15 Shukla et al. examined a variety of herbal remedies for the treatment of DM, including aloe vera, eucalyptus, garlic, and ginger.16 Chia (Salvia hispanica L.), which belongs to the genus Salvia,17 is a plant native to northern Guatemala and southern Mexico. It was used as a nutritional food source by pre-Columbian populations.18 Chia is distinguished by its high content of alpha-linolenic acid (omega-3), fiber, proteins, vitamins, minerals, and phytonutrients, including phenolic compounds.19 These constituents contribute to improvements in biological markers associated with non-communicable diseases, exhibiting anti-inflammatory,20 antioxidant,21 hypotensive,22 hypocholesterolemic,23 and hypoglycemic properties.24

Chia may assist in the prevention of cardiovascular diseases, inflammatory and neurological disorders, as well as diabetes, as stated by Vuksan et al., who proposed that a high-fiber diet may contribute to the management of diabetes.25 The study was carried out on 20 patients with diabetes, who were given bread made with chia flour and additional whole seeds to be sprinkled on foods at home. The total consumption of chia seeds was 37 g/day. The study results demonstrated a small reduction in blood glucose as well as reduced levels of systemic inflammation, measured by C-reactive protein (CRP). Notably, blood became less susceptible to coagulation, which constitutes a risk factor that may lead to heart attacks and strokes.25

Objectives

This study aimed to assess the therapeutic efficacy of chia seeds in ameliorating salivary gland dysfunction caused by DM in diabetic rats.

Material and methods

A total of 66 mature male albino rats, weighing 200–250 g, were utilized in the current research. The animals were housed in separate cages and provided with a standard rodent diet and water. Prior to the study, the rats were administered chia seeds for 14 days. The animals were divided into the following 3 groups:

• group I (control group; n = 6) – administered a saline solution;

• group II (n = 30) – subjected to diabetic induction via a single intraperitoneal injection of STZ without additional treatment;

• group III (n = 30) – subjected to diabetic induction via a single intraperitoneal injection of STZ and treated with 250 mg/kg/day of chia seed flour for 2 weeks prior to diabetic induction and until the end of the study.26

The study design is presented in Figure 1.

Parotid and mandibular mucosal gland assessment

The rats were euthanized by an overdose of halothane 45 days after diabetic induction.27 The parotid and mandibular mucosal glands were removed (Figure 2) and divided as follows:

• 2 rats from group I, 10 rats from group II and 10 rats from group III were used for histological examination by hematoxylin and eosin (H&E) staining. The excised glands were fixed in 10% neutral-buffered formalin for 24 h, immersed in paraffin and sectioned at 5 μm;

• 2 rats from group I, 10 rats from group II and 10 rats from group III were used for immunohistochemical examination of vascular endothelial growth factor (VEGF). The excised glands were preserved in 10% neutral-buffered formalin for 24 h, immersed in paraffin and sectioned at 5 μm. Subsequently, they were immunostained using the avidin–biotin method. The sections were stained with rabbit anti-rat VEGF polyclonal antibodies (Sigma-Aldrich, St. Louis, USA);

• 2 rats from group I, 10 rats from group II and 10 rats from group III were used for single-cell gel electrophoresis (comet assay). The excised glands were stored in 1 mL of saline solution in Eppendorf tubes at −180°C.28, 29

Histological staining

Hematoxylin and eosin staining was performed as a routine histological procedure. For microscopic analysis, the excised glands were fixed in 10% formalin for 24 h. The specimens were washed thoroughly under running water, dehydrated through a graded series of alcohol, cleared in xylene, and embedded in paraffin wax according to standard techniques.30 After embedding in paraffin, 5 μm-thick sections were cut and stained with H&E.

These histological sections were investigated under a light microscope (Olympus CH2; Olympus Optical Co., Ltd., Tokyo, Japan).

Immunohistochemical evaluation

The sectioned glands were subjected to immunostaining using the avidin–biotin technique. The sections were stained with rabbit anti-rat VEGF polyclonal antibodies (Sigma-Aldrich).

Five non-overlapping fields from each slide were digitized using a digital camera (Olympus Optical Co., Ltd.) mounted on a microscope (Olympus CH2). The images were analyzed on an Intel Core i3-based computer using VideoTesT-Morphology software (Video Test, Saint Petersburg, Russia) with a specific built-in routine for immunostain quantification. The targeted, positively immunostained areas were automatically selected and separated from the original image based on the stain hue range. The selected area was thresholded and defined as a region of interest. Subsequently, a 3D histogram was constructed, and the integrated density of the area was calculated.31

Diabetes induction

Experimental diabetes was induced in rats from groups II and III after overnight fasting32 by a single intraperitoneal injection of STZ (STZ: 45 mg/kg body weight in 0.1 mL citrate buffer, pH 4.5). Three days after the injection, the presence of diabetes was confirmed by hyperglycemia (non-fasting blood glucose level >300 mg/dL) using a blood glucose meter.33 The blood glucose levels were monitored at 3 and 45 days after induction, and the results are presented in Table 1.

Comet assay

The comet assay,28, 29 also referred to as single-cell gel electrophoresis, is a rapid and highly sensitive fluorescence microscopy-based technique for the assessment of DNA damage and repair in individual nucleated cells. The method is based on the measurement of the ability of denatured, cleaved DNA fragments to migrate out of the cell under the influence of an electric field, whereas undamaged DNA migrates more slowly and remains within the nucleoid. The evaluation of the DNA “comet” tail shape and migration pattern allows for the assessment of DNA damage. In this assay, cells are immobilized in a layer of low-melting-point agarose, followed by gentle cell lysis, and treated with alkaline solution to unwind and denature the DNA and hydrolyze sites of damage. The samples are then submitted to electrophoresis, stained with a fluorescent DNA-intercalating dye, and visualized using epifluorescence microscopy.35

Chia administration

Group III received a daily dose of 250 mg/kg of chia seeds (PLANTON, New Delhi, India).26 The doses used in animal studies vary from 3.0% to 41.3% for chia seeds, and from 0.15% to 10.00% for chia oil, as reported by Enes et al.34 Freshly prepared seeds were minced and immersed in water 1 day prior to administration via a stomach tube. The administration was commenced 2 weeks before the induction of diabetes and continued until the end of the experiment.26

Statistical analysis

The data was analyzed using the IBM SPSS Statistics for Windows software, v. 20.0 (IBM Corp., Armonk, USA). The results are presented as mean ± standard deviation (M ±SD). Differences between the groups were assessed using one-way analysis of variance (ANOVA). Subsequently, a post hoc least significant difference (LSD) test was performed. Values were considered statistically significant at p < 0.05.

The DNA fragmentation pattern was estimated using a computer-assisted image analysis system (Comet Assay IV; Perceptive Instruments). A total of 100 haphazardly selected cells per slide were recorded. DNA damage was assessed by evaluating the percentage of DNA in the comet tail relative to the total cellular DNA content.

Results

Clinical observations

A total of 8 rats were excluded from the study, as 5 rats died within 24 h after diabetes induction, and in group II, 2 rats died 1 week after diabetes induction, and 1 rat died after the 2nd week of diabetes induction. The rats were replaced to maintain group sizes.

Histological evaluation

In group I, the parotid glands revealed a normal architecture of serous acini with pyramidal cells and a rounded basally located nucleus arranged around a small lumen (Figure 3A). The evaluation of the mandibular mucosal glands revealed the presence of typical mucous acini with oval, basally located nuclei encircling a broader lumen. The intralobular ducts of both glands were lined with columnar cells with centrally placed, large, rounded nuclei (Figure 3E).

In group II, the examination of parotid sections revealed loss of the normal acinar architecture with signs of deterioration. The nuclei were irregularly arranged, with variable sizes and shapes (Figure 3B,C). Mandibular mucosal gland sections demonstrated atrophy of the acini, and some showed loss of architecture. The intralobular ducts of both glands revealed degenerative changes and loss of normal structure (Figure 3F,G).

In group III, the sections of both glands revealed improvement in acinar structure. Additionally, the intralobular ducts re-established their normal architecture (Figure 3D,H).

Immunohistochemical evaluation

In group I, positive cytoplasmic staining was observed in the cells of both acini and ducts in the parotid and mandibular mucosal glands. In group II, a weak positive reaction was reported. In group III, acinar cells exhibited moderate positivity, which was lower than that reported in group I. Ductal cells presented stronger positive staining compared to group II (Figure 4). The expression of VEGF in the parotid and mandibular mucosal glands in all groups is presented in Table 2.

The results of one-way ANOVA and the post hoc LSD test for VEGF expression in the parotid and mandibular mucosal glands in all groups are presented in Table 3 and Table 4.

Comet assay analysis

The comet assay was conducted to examine the degree of cellular DNA damage in the parotid and mandibular mucosal gland cells in all groups. In group I, the majority of cells were observed as uniform discs, characterized by low tail moment, short tail length and a low percentage of tail DNA.

In group II, in both glands, the percentage of tailed cells, tail length, tail moment, and the percentage of tail DNA were significantly increased in comparison to group I. In group III, in both glands, the tail moment, tail length and the percentage of tailed cells were markedly reduced compared to group II (Figure 5, Figure 6).

The mean values of comet assay parameters were calculated for the parotid and mandibular mucosal glands in all groups, including the percentage of tail DNA, tail moment, tail length, and the percentage of tailed and untailed cells (Figure 7, Figure 8).

The results of comet assay in the parotid and mandibular mucosal glands for the 3 groups are presented in Table 5 and Table 6.

Discussion

The current study investigated the efficacy of chia seeds in restoring the architecture and histological integrity of the parotid and mandibular mucosal glands in rats with STZ-induced diabetes. Streptozotocin is widely used for the experimental induction of diabetes. Streptozotocin-induced diabetes in rats provides a reliable and well-established model for studying the deleterious effects of diabetes on multiple systems.36

The diabetic status induced by the administration of STZ was confirmed by elevated levels of serum glucose, nitric oxide and MDA. The administration of a single dose of STZ initiates an autoimmune process leading to the destruction of the Langerhans islet beta cells, resulting in the development of clinical diabetes within a short period (2–4 days) and the induction of oxidative stress.37

In the current study, the parotid gland specimens in group II demonstrated loss of normal acinar architecture with degenerative changes. The nuclei were irregularly arranged, with variable sizes and shapes. The intralobular ducts revealed deterioration and loss of normal structure. These findings are consistent with results of study by Cui et al., who reported serous acinar cell distortion and disintegration with reduced secretory granules, vacuolization and leukocyte invasion in the salivary glands of diabetic rats.38 In the present study, the observed changes in blood vessels may be attributed to the inflammatory processes associated with DM, as stated by Ror et al.39

In group II, the mandibular mucosal gland sections demonstrated acinar atrophy with loss of normal architecture, as well as deterioration and structural disruption of the intralobular ducts, which is in agreement with the findings of Stewart et al., who confirmed that diabetes is associated with hypofunction and atrophy of the parotid and mandibular mucosal salivary glands in diabetic rats due to reduced nitric oxide synthase activity, which is important for the proper functioning of salivary glands.40 These findings may be explained by the deleterious effects of chronic hyperglycemia, which promote oxidative stress.41 Oxidative stress results from multiple pathways, including glucose autoxidation, activation of the polyol pathway, and the formation of advanced glycation end-products (AGEs).42 Other circulating factors reported to be elevated during the course of diabetics, namely free fatty acids and leptin, are also associated with the increased production of ROS.43

Krippeit-Drews et al. explained the mechanisms of oxidative stress-induced cell injury through both indirect and direct pathways.44 Indirect pathways include the release of calcium from intracellular stores and its influx across the plasma membrane. The increased number of cytosolic calcium ions activates enzymes responsible for cellular damage, including phospholipases, proteases, endonucleases, and adenosine triphosphatases (ATPases), thereby accelerating ATP reduction. This ATP depletion causes structural disruption of protein synthesis. Moreover, ATP reduction impairs the activity of the plasma membrane energy-dependent sodium pump, leading to intracellular aggregation of Na+ and loss of K+, resulting in cell enlargement and dilation of the endoplasmic reticulum.44 Hyperglycemia may also impair the function of sodium–glucose cotransporters and aquaporins, affecting cellular water balance.45

Conversely, direct pathways include peroxidation of polyunsaturated membrane lipids, which are susceptible to attack by oxygen-derived free radicals. Lipid radical interactions generate peroxides that compromise the integrity of cellular and nuclear membranes. This permits oxygen radicals to attack chromatin, leading to DNA disintegration. Additionally, free radicals react with thymine in nuclear and mitochondrial DNA, causing single-strand breaks. This DNA damage contributes to cellular aging and apoptosis.46

Whole chia seeds were administered in the form of flour since the particle size directly influences digestion and metabolic processes.47 Furthermore, whole seed flour retains all structural components of the grain, including endosperm, bran, germ, and coat.48 Moreover, grinding enhances the bioaccessibility of bioactive antioxidants, such as phenolic acids, thereby increasing their potential health benefits.49

In group III, which was subjected to diabetic induction and treated with chia seeds, the parotid and mandibular mucosal glands showed improvement in acinar architecture and intralobular duct structure. These findings indicate that chia seeds might have an ameliorative effect on salivary glands affected by diabetes-induced degeneration. Moreover, Enes et al. reported similar findings regarding the effects of chia seeds on glucose metabolism in both in vitro and in vivo studies.34 The authors demonstrated that chia flour and chia oil decreased adiposity; however, only chia oil was able to improve glucose tolerance and restore the energy fuel system in the liver of rats fed a high-fat high-fructose (HFHF) diet. In addition, chia hydroalcoholic protein extract (CHPE) decreased the mRNA expression levels of gluconeogenic enzymes.34

In addition, de Paula Dias Moreira et al. stated that the inclusion of chia flour or chia oil in an unbalanced diet rich in saturated fat and fructose promoted beneficial effects on liver health by reducing metabolic disturbances through modulation of different metabolic pathways.50 Chia flour and chia oil restored antioxidant system activity and enhanced fatty acid oxidation. Furthermore, chia flour modulated lipogenesis, whereas chia oil improved blood glucose levels, triglyceride (TG) levels and body weight.50

Chia seeds contain a wide range of antioxidant compounds, including vitamins C and E, carotenoids, phenolic compounds, and polyphenols such as flavonoids.51 The flavonoid group with antioxidant activity includes flavones, flavonols, isoflavones, catechins, and chalcones. Micronutrients present in plants, such as vitamins A, C and E, folic acid, carotenoids, anthocyanins, and polyphenols, can scavenge free radicals and may serve as natural alternatives to synthetic antioxidants.52

Furthermore, chia is one of the most notable natural sources of omega-3 fatty acids, which inhibit the production of prostaglandins and pro-inflammatory cytokines, thereby modulating the inflammatory response and indirectly reducing cellular damage.53 Additionally, the high levels of α-linolenic acid support the function of the epithelial barrier by maintaining the integrity of intercellular junction proteins.54

In a study conducted by Enes et al., the extraction of chia seeds into chia oil was shown to significantly reduce blood glucose levels.55 The consumption of chia seeds has been associated with the restoration of lipids and membrane fatty acid translocase (FAT/CD36) in the plasma membrane, as well as with enhanced mitochondrial function and beta-oxidation.56 The distribution of lipids may improve glucose tolerance by reducing body adiposity, an effect that has been associated with α-lipoic acid. Alpha-lipolic acid acts as an activator of adenosine monophosphate-activated protein kinase (AMPK). The activation of AMPK reduces blood glucose levels by promoting the phosphorylation of Akt substrate of 160 kDa (AS160), a protein active in glucose transporters, thereby enhancing insulin-dependent glucose uptake.57

A study conducted by Hassan Mahmoud et al. further supported the antioxidant activity of chia seeds.26 The authors investigated the impact of low-level laser therapy (LLLT) and chia seeds on the alleviation of photoreceptor aberrations in experimental diabetic retinopathy (DR) and reported that the association between LLLT and the antioxidant action of chia seeds accelerated the recovery of retinal photoreceptors. They demonstrated that in DR, the production of ROS is elevated during the early stages of diabetes, leading to structural damage to mitochondria in photoreceptors. Additionally, persistent hyperglycemia results in the excessive production of ROS, continuous mitochondrial damage and elevated oxidative stress. Chia seeds reduced oxidative stress and hastened photoreceptor layer (PRL) mitigation, likely due to their antioxidant properties.26

Vascular endothelial growth factor has a pleiotropic role in tissue repair via angiogenesis, re-epithelialization and maintenance of extracellular matrix balance.58 In group II, the expression of VEGF in acinar and ductal cells was reduced compared to groups I and III, which may be attributed to the adverse effects of diabetes on vascular function, including increased endothelial permeability to macromolecules and impaired endothelial proliferation.59 Radwan et al. also investigated the antidiabetic effect of bee venom compared with bone marrow mesenchymal stem cells on the rat tongue using VEGF as an indicator of regeneration. Comparable results were obtained, as VEGF expression in the diabetic group was lower than in the treated groups.60 Diabetes also disrupts the balance between cell proliferation and apoptosis.61 Studies on cutaneous wound healing in diabetic models have shown delayed re-epithelialization, absence of growth factors and decreased angiogenesis.62

The alkaline comet assay is utilized as a conventional technique for the identification of DNA damage in genotoxicity testing and human biomonitoring.63 Furthermore, it is an accepted method in ecotoxicology and environmental monitoring for the study of various animal and plant species.64 Hyperglycemia in DM increases the production of ROS, thus enhancing endothelial cell apoptosis in vivo and in vitro, promoting free radical formation and reducing antioxidant capacity due to glycation and lipid oxidation reactions.65 Oxidative modifications to DNA occur due to alterations of nucleotide bases and sugars, as well as the formation of cross-links, leading initially to base oxidation and fragmentation, followed by single- and double-strand breaks, interstrand and intrastrand cross-links, and eventually DNA–protein cross-links and sugar fragmentation products.66

In the current study, group II of both glands presented increased DNA damage, as evidenced by greater DNA tail length, higher percentage of tail DNA, and increased tail moment (defined as the product of tail length and the fraction of total DNA in the tail) compared to group I. In group III, DNA damage was markedly reduced following treatment with chia seeds compared to group II, indicating that the extent of oxidative stress correlates with the size of comet tail. These findings confirm the ability of chia seeds to ameliorate the deleterious effects of DM on salivary glands, as reflected by the improvement in acinar and ductal architecture. Moreover, the phenolic compounds present in chia seeds include flavonols and phenolic acids, such as myricetin, quercetin, kaempferol, and caffeine acid.67 These compounds act as primary and synergistic antioxidants, contributing to the overall antioxidant activity of chia seeds. Quercetin, in particular, is a powerful antioxidant that inhibits the oxidation of fats, proteins and DNA, and exhibits stronger antioxidant activity compared to other flavonoids.68

Limitations

The present research was conducted using an experimental animal model. Although such model provides invaluable insights, findings of the study cannot be directly extrapolated to humans. Moreover, the study did not include the monitoring of blood glucose levels before, during and after the administration of chia seeds.

Conclusions

The immunohistochemical and genotoxic results obtained from the present study demonstrated that diabetes induction leads to significant structural changes in the parotid and mandibular mucosal glands in rats, primarily through oxidative DNA damage. Treatment with chia seeds ameliorated these changes, likely due to their antioxidant properties. Chia seeds showed promising effects in reducing oxidative stress. However, further studies are required, including investigations with different treatment durations and dosages, to support the use of chia as a dietary supplement in the management of DM. Further research should also evaluate long-term safety, identify bioactive compounds, and elucidate the underlying mechanisms. Additionally, studies should assess the effects of chia seeds on salivary gland function (flow rate and composition) to better understand their potential clinical relevance. The interactions between the various bioactive compounds of chia seeds, as well as the specific compound or synergistic effect responsible for their observed health benefits, remain unclear.

Ethics approval and consent to participate

The study was approved by the Institutional Animal Care at Faculty of Medicine, Mansoura University, Egypt (approval No. A 11070898). The research was conducted in accordance with the ARRIVE (Animal Research: Reporting of in Vivo Experiments) guidelines and regulations (https://arriveguidelines.org). The maintenance and care of the experimental animals adhered to the International Guiding Principles for Biomedical Research Involving Animals.

Data availability

The datasets generated and/or analyzed during the current study are available from the corresponding author on reasonable request.

Consent for publication

Not applicable.

Use of AI and AI-assisted technologies

Not applicable.

Tables


Table 1. Blood glucose levels measured at 3 and 45 days after diabetic induction across the groups

Time period

Group I

Group II

Group III

ANOVA

F

p-value

3 days after diabetic induction

90.56 ±73.70Aa

384.25 ±32.74Ba

293.33 ±35.02AB

20.08

<0.001*

45 days after diabetic induction

105.83 ±19.64Aa

518.25 ±35.14a

195.50 ±40.99A

341.80

<0.001*

Data expressed as mean ± standard deviation (±SD); * statistically significant (< 0.05); ANOVA – analysis of variance. The same capital letters indicate statistically significant differences between the groups. The same lowercase letters indicate statistically significant differences between day 3 and day 45 within the groups.
Table 2. Vascular endothelial growth factor (VEGF) expression in the parotid and mandibular salivary glands across the groups

Group

Gland type

VEGF expression [pg/mL]

Group I

parotid

5.1 ±0.4

submandibular

3.6 ±0.6

Group II

parotid

1.6 ±1.4

submandibular

1.5 ±0.6

Group III

parotid

3.2 ±0.5

submandibular

2.5 ±0.4

Data expressed as ±SD.
Table 3. Results of one-way analysis of variance (ANOVA) and post hoc least significant difference (LSD) test for vascular endothelial growth factor (VEGF) expression in the parotid glands across the groups

Variable

One-way ANOVA (p-value)

Post hoc LSD test

comparison

p-value

VEGF expression

0.001*

group I

group II

0.001*

group III

0.001*

group II

group I

0.001*

group III

0.004*

group III

group I

0.001*

group II

0.004*

* statistically significant (< 0.05).
Table 4. Results of one-way analysis of variance (ANOVA) and post hoc least significant difference (LSD) test for vascular endothelial growth factor (VEGF) expression in the mandibular salivary glands across the groups

Variable

One-way

ANOVA (p-value)

Post hoc LSD test

comparison

p-value

VEGF expression

0.001*

group I

group II

0.004*

group III

0.001*

group II

group I

0.004*

group III

0.001*

group III

group I

0.001*

group II

0.001*

* statistically significant (< 0.05).
Table 5. Comet assay results in the parotid salivary glands across the groups

Variable

Group I

Group II

Group III

Tail moment

3.45 ±0.52

14.53 ±2.65a

8.62 ±1.33ab

Tail DNA

[%]

1.76 ±0.49

4.31 ±0.63a

2.37 ±0.34b

Tail length

[µm]

1.90 ±0.37

3.72 ±0.50a

2.05 ±0.45b

Untailed cells

[%]

97.00 ±13.73

81.00 ±11.50

91.00 ±14.00

Tailed cells

[%]

5.00 ±0.63

18.00 ±2.17a

10.00 ±1.52ab

Data expressed as ±SD; a statistically significant compared to group I (control group); b statistically significant compared to group II (one-way ANOVA followed by Tukey’s post hoc test). Tail moment was calculated based on the tail length and tail DNA.
Table 6. Comet assay results in the mandibular salivary glands across the groups

Variable

Group I

Group II

Group III

Tail moment

3.72 ±0.82

8.53 ±2.65a

5.32 ±1.33ab

Tail DNA

[%]

1.36 ±0.49

3.31 ±0.21a

2.47 ±0.30b

Tail length

[µm]

1.81 ±0.17

2.82 ±0.70a

2.05 ±0.45b

Untailed cells

[%]

98.00 ±13.73

90.03 ±11.50

92.00 ±34.00

Tailed cells

[%]

5.00 ±0.43

9.00 ±1.17a

7.00 ±1.52ab

Data expressed as ±SD; a statistically significant compared to group I (control group); b statistically significant compared to group II (one-way ANOVA followed by Tukey’s post hoc test).

Figures


Fig. 1. Flowchart of the study design
STZ – streptozotocin; H&E – hematoxylin and eosin; VEGF – vascular endothelial growth factor; SCGE – single-cell gel electrophoresis; IP – intraperitoneal.
Fig. 2. Location of the parotid gland (A) and mandibular mucosal salivary gland (B)
Fig. 3. Photomicrographs of the parotid and mandibular mucosal salivary glands (hematoxylin and eosin (H&E) staining, ×400 magnification)
A. Parotid gland of the control group showing normal architecture of serous acini composed of pyramidal cells with basally located spherical nuclei surrounding a narrow lumen; B. Parotid gland of group II demonstrating loss of normal acinar structure with degenerative changes, irregularly arranged nuclei with variable sizes and shapes, darkly stained nuclei, and thinning of the epithelial lining of the intralobular ducts (arrow); C. Parotid gland of group II showing dilated duct (arrow), dilated blood vessels (star) and intercellular vacuolation (arrowheads); D. Parotid gland of group III demonstrating apparent improvement of the acinar structure and intralobular ducts; E. Mandibular mucosal salivary glands of the control group showing normal mucous acini with oval, basally located nuclei surrounding a wide lumen; F. Mandibular mucosal salivary glands of group II demonstrating acinar atrophy (arrows), reduced acinar size (arrowhead), signs of degeneration in the intralobular ducts, and loss of normal architecture; G. Mandibular mucosal salivary glands of group II demonstrating degeneration of mucous acini (arrow) and dilated duct (arrowhead); H. Mandibular mucosal salivary glands of group III showing improved acinar structure and restoration of intralobular duct architecture (arrows).
Fig. 4. Representative images of vascular endothelial growth factor (VEGF) immunoreactivity in the parotid and mandibular mucosal salivary glands (×400 magnification)
A. Group I – positive reaction in acinar (arrow) and ductal cells (arrowhead) of the parotid gland; B. Group II – weak positive reaction in acinar (arrow) and ductal cells (arrowhead) of the parotid gland; C. Group III – moderate positive reaction in acinar cells (arrows), lower than in group I; D. Group I – stronger positive reaction in ductal cells (arrowhead) than in acinar cells (arrows) of the mandibular mucosal salivary glands; E. Group II – minimal positive reaction in acinar (arrows) and ductal cells (arrowhead) of the mandibular mucosal salivary glands; F. Group III – increased reaction in acinar (arrow) and ductal cells (arrowhead) of the mandibular mucosal salivary glands.
Fig. 5. Representative comet assay images of acinar cells from the parotid salivary glands
A. Group I; B. Group II; C. Group III.
The dark, round areas represent intact DNA without migration, whereas the brighter comet-shaped areas adjacent to the nucleus represent DNA damage.
Fig. 6. Representative comet assay images of acinar cells from the mandibular mucosal salivary glands
A. Group I; B. Group II; C. Group III.
The dark, round areas represent intact DNA without migration, whereas the brighter comet-shaped areas adjacent to the nucleus represent DNA damage.
Fig. 7. Column charts showing mean values of comet assay parameters in the parotid salivary glands across all groups
Tail moment was calculated based on the tail length and tail DNA.
Fig. 8. Column chart showing mean values of comet assay parameters in the mandibular mucosal salivary glands across all groups

References (68)

  1. Bakianian Vaziri P, Vahedi M, Mortazavi H, Abdollahzadeh S, Hajilooi M. Evaluation of salivary glucose, IgA and flow rate in diabetic patients: A case–control study. J Dent (Tehran). 2010;7(1):13–18. PMID:21998770.
  2. Soares MSM, Batista-Filho MMV, Pimentel MJ, Passos IA, Chimenos-Küstner E. Determination of salivary glucose in healthy adults. Med Oral Patol Oral Cir Bucal. 2009;14(10):e510–e513. doi:10.4317/medoral.14.e510
  3. Park J, Jang HJ. Anti-diabetic effects of natural products an overview of therapeutic strategies. Mol Cell Toxicol. 2017;13(1):1–20. doi:10.1007/s13273-017-0001-1
  4. Attia MA, Hassan SS. Expression of cytokeratin, actin and proliferating cell nuclear antigen (PCNA) in parotid gland of normal and alloxan-induced diabetic dogs. (Histological and immunohistochemical study). Cairo Dent J. 2015;31(2):2661–2674.
  5. Wang B, Du J, Zhu Z, Ma Z, Wang S, Shan Z. Evaluation of parotid salivary glucose level for clinical diagnosis and monitoring type 2 diabetes mellitus patients. Biomed Res Int. 2017;2017:2569707. doi:10.1155/2017/2569707
  6. Peralta I, Marrassini C, Barreiro Arcos ML, Cremaschi G, Alonso MR, Anesini C. Larrea divaricata Cav. aqueous extract and nordihydroguariaretic acid modulate oxidative stress in submandibular glands of diabetic rats: A buccal protective in diabetes. BMC Complement Altern Med. 2019;19:227. doi:10.1186/s12906-019-2636-z
  7. Mauri-Obradors E, Estrugo-Devesa A, Jané-Salas E, Viñas M, López-López J. Oral manifestations of diabetes mellitus. A systematic review. Med Oral Patol Oral Cir Bucal. 2017;22(5):e586–e594. doi:10.4317/medoral.21655
  8. Carda C, Mosquera-Lloreda N, Salom L, Gomez de Ferraris ME, Peydró A. Structural and functional salivary disorders in type 2 diabetic patients. Med Oral Patol Oral Cir Bucal. 2006;11(4):E309–E314. PMID:16816810.
  9. Rohani B. Oral manifestations in patients with diabetes mellitus. World J Diabetes. 2019;10(9):485–489. doi:10.4239/wjd.v10.i9.485
  10. Kaludercic N, Di Lisa F. Mitochondrial ROS formation in the pathogenesis of diabetic cardiomyopathy. Front Cardiovasc Med. 2020;7:12. doi:10.3389/fcvm.2020.00012
  11. Knaś M, Maciejczyk M, Daniszewska I, et al. Oxidative damage to the salivary glands of rats with streptozotocin-induced diabetes-temporal study: Oxidative stress and diabetic salivary glands. J Diabetes Res. 2016;2016:4583742. doi:10.1155/2016/4583742
  12. César M, Justo R, Vidal J, Bonel M, Migowski E, Cisne R. The use of drugs for the treatment of xerostomia – brief review. IJOBAS. 2016;5(4):238–244. doi:10.14419/IJBAS.V5I4.6708
  13. American Diabetes Association. Standards of medical care in diabetes – 2009. Diabetes Care. 2009;32(Suppl 1):S13–S61. doi:10.2337/dc09-S013
  14. Campbell-Tofte JI, Mølgaard P, Winther K. Harnessing the potential clinical use of medicinal plants as anti-diabetic agents. Bot Targets Ther. 2012;2:7–19. doi:10.2147/BTAT.S17302
  15. Allen DA, Yaqoob MM, Harwood SM. Mechanisms of high glucose-induced apoptosis and its relationship to diabetic complications. J Nutr Biochem. 2005;16(12):705–713. doi:10.1016/j.jnutbio.2005.06.007
  16. Shukla A, Bukhariya V, Mehta J, et al. Herbal remedies for diabetes: An overview. Int J Biomed Adv Res. 2011;2(1):57–68.
  17. Gupta P, Geniza M, Elser J, et al. Reference genome of the nutrition-rich orphan crop chia (Salvia hispanica) and its implications for future breeding. Front Plant Sci. 2023;14:1272966. doi:10.3389/fpls.2023.1272966
  18. Ayerza R. The seed’s protein and oil content, fatty acid composition, and growing cycle length of a single genotype of chia (Salvia hispanica L.) as affected by environmental factors. J Oleo Sci. 2009;58(7):347–354. doi:10.5650/jos.58.347
  19. da Silva BP, Anunciação PC, Matyelka JCS, Della Lucia CM, Martino HSD, Pinheiro-Sant’Ana HM. Chemical composition of Brazilian chia seeds grown in different places. Food Chem. 2017;221:1709–1716. doi:10.1016/j.foodchem.2016.10.115
  20. Hamedi A, Jamshidzadeh A, Ahmadi S, Sohrabpour M, Zarshenas MM. Salvia macrosiphon seeds and seed oil: Pharmacognostic, anti-inflammatory and analgesic properties. Res J Pharmacogn. 2016;3(4):27–37. https://www.rjpharmacognosy.ir/article_33342_a9a7d9989a71bd19ec1969b5127ae616.pdf. Accessed February 1, 2024.
  21. Scapin G, Schmidt MM, Prestes RC, Rosa CS. Phenolics compounds, flavonoids and antioxidant activity of chia seed extracts (Salvia hispanica) obtained by different extraction conditions. Int Food Res J. 2016;23(6):2341–2346. https://www.cabidigitallibrary.org/doi/full/10.5555/20173079231. Accessed February 1, 2016.
  22. Toscano LT, da Silva CSO, Toscano LT, de Almeida AEM, Santos AC, Silva AS. Chia flour supplementation reduces blood pressure in hypertensive subjects. Plant Foods Hum Nutr. 2014;69(4):392–398. doi:10.1007/s11130-014-0452-7
  23. Tavares Toscano L, Tavares Toscano L, Leite Tavares R, da Oliveira Silva CS, Silva AS. Chia induces clinically discrete weight loss and improves lipid profile only in altered previous values. Nutr Hosp. 2014;31(3):1176–1182. doi:10.3305/nh.2015.31.3.8242
  24. Fonte-Faria T, Citelli M, Atella GC, et al. Chia oil supplementation changes body composition and activates insulin signaling cascade in skeletal muscle tissue of obese animals. Nutrition. 2019;58:167–174. doi:10.1016/j.nut.2018.08.011
  25. Vuksan V, Whitman D, Sievenpiper JL, et al. Supplementation of conventional therapy with the novel grain Salba (Salvia hispanica L.) improves major and emerging cardiovascular risk factors in type 2 diabetes: Results of a randomized controlled trial. Diabetes Care. 2007;30(11):2804–2810. doi:10.2337/dc07-1144
  26. Hassan Mahmoud AR, Abdelkawi SA, Ghoneim DF, Hassan AA, Morsy ME. Mitigation of photoreceptors abnormalities after low-level laser therapy and chia seeds supplementation in experimental diabetic retinopathy. Oman J Ophthalmol. 2022;15(3):347–352. doi:10.4103/ojo.ojo_251_21
  27. Alqahtani MS, Hassan SS. Immunohistochemical evaluation of the pathological effects of diabetes mellitus on the major salivary glands of albino rats. Eur J Dent. 2023;17(2):485–491. doi:10.1055/s-0042-1749159
  28. Dhawan A, Bajpayee M, Pandey AK, Parmar D. Protocol for the single cell gel electrophoresis/comet assay for rapid genotoxicity assessment. ITRC: THE SCGE/COMET ASSAY PROTOCOL. 2009:1–10.
  29. Nandhakumar S, Parasuraman S, Shanmugam MM, Ramachandra R, Parkash C, Vishnu Bhat B. Evaluation of DNA damage using single-cell gel electrophoresis (comet assay). J Pharmacol Pharmacother. 2011;2(2):107–111. doi:10.4103/0976-500X.81903
  30. Bancroft JD, Layton C. The hematoxylin and eosin. In: Suvarna SK, Layton C, Bancroft JD, eds. Theory and Practice of Histological Techniques. 7th ed. Philadelphia, PA: Churchill Livingstone; 2013:173–186. doi:10.1016/B978-0-7020-4226-3.00010-X
  31. Al-Dissi AN, Haines DM, Singh B, Kidney BA. Immunohistochemical expression of vascular endothelial growth factor and vascular endothelial growth factor receptor-2 in canine simple mammary gland adenocarcinomas. Can Vet J. 2010;51(10):1109–1114. PMID:21197202.
  32. Belkacemi L, Selselet-Attou G, Hupkens E, et al. Intermittent fasting modulation of the diabetic syndrome in streptozotocin-injected rats. Int J Endocrinol. 2012;2012:962012. doi:10.1155/2012/962012
  33. Hie M, Shimono M, Fujii K, Tsukamoto I. Increased cathepsin K and tartrate-resistant acid phosphatase expression in bone of streptozotocin-induced diabetic rats. Bone. 2007;41(6):1045–1050. doi:10.1016/j.bone.2007.08.030
  34. Enes BN, Moreira LPD, Toledo RCL, et al. Effect of different fractions of chia (Salvia hispanica L.) on glucose metabolism, in vivo and in vitro. J Funct Foods. 2020;71:104026. doi:10.1016/j.jff.2020.104026
  35. Balasubramanyam M, Adaikalakoteswari A, Sameermahmood Z, Mohan V. Biomarkers of oxidative stress: Methods and measures of oxidative DNA damage (COMET assay) and telomere shortening. Methods Mol Biol. 2010;610:245–261. doi:10.1007/978-1-60327-029-8_15
  36. Thrailkill KM, Nyman JS, Bunn RC, et al. The impact of SGLT2 inhibitors, compared with insulin, on diabetic bone disease in a mouse model of type 1 diabetes. Bone. 2017;94:141–151. doi:10.1016/j.bone.2016.10.026
  37. Turner S, Zettler G, Barreiro Arcos ML, Cremaschi G, Davicino R, Anesini C. Effect of streptozotocin on reactive oxygen species and antioxidant enzymes’s secretion in rat submandibulary glands: A direct and an indirect relationship between enzyme activation and expression. Eur J Pharmacol. 2011;659(2–3):281–288. doi:10.1016/j.ejphar.2011.03.015
  38. Cui F, Hu M, Li R, et al. Insulin on changes in expressions of aquaporin-1, aquaporin-5, and aquaporin-8 in submandibular salivary glands of rats with streptozotocin-induced diabetes. J Clin Exp Pathol. 2021;14(2):221–229. PMID:33564354.
  39. Ror FN, Col LO, Moura EG, Jaciara MA, Caldeira EJ. N-acetylcysteine, anti-CD4/CD8 antibodies, and physical exercise reduces histopathological damage in salivary glands of spontaneously diabetic mice. Austin Endocrinol Diabetes Case Rep. 2018;3(1):1013–1018. https://austinpublishinggroup.com/diabetes-case-reports/fulltext/diabetescr-v3-id1013.pdf. Accessed March 1, 2021.
  40. Stewart CR, Obi N, Epane EC, et al. Effects of diabetes on salivary gland protein expression of tetrahydrobiopterin and nitric oxide synthesis and function. J Periodontol. 2016;87(6):735–741. doi:10.1902/jop.2016.150639
  41. Mednieks MI, Szczepanski A, Clark B, Hand AR. Protein expression in salivary glands of rats with streptozotocin diabetes. Int J Exp Pathol. 2009;90(4):412–422. doi:10.1111/j.1365-2613.2009.00662.x
  42. Jay D, Hitomi H, Griendling KK. Oxidative stress and diabetic cardiovascular complications. Free Radic Biol Med. 2006;40(2):183–192. doi:10.1016/j.freeradbiomed.2005.06.018
  43. Murphy MP. How mitochondria produce reactive oxygen species. Biochem J. 2009;417(1):1–13. doi:10.1042/BJ20081386
  44. Krippeit-Drews P, Kramer C, Welker S, Lang F, Ammon HP, Drews G. Interference of H2O2 with stimulus-secretion coupling in mouse pancreatic beta-cells. J Physiol. 1999;514(Pt 2):471–481. doi:10.1111/j.1469-7793.1999.471ae.x
  45. El Sadik A, Mohamed E, El Zainy A. Postnatal changes in the development of rat submandibular glands in offspring of diabetic mothers: Biochemical, histological and ultrastructural study. PLoS One. 2018;13(10):e0205372. doi:10.1371/journal.pone.0205372
  46. Pizzimenti S, Toaldo C, Pettazzoni P, Dianzani MU, Barrera G. The “two-faced” effects of reactive oxygen species and the lipid peroxidation product 4-hydroxynonenal in the hallmarks of cancer. Cancers (Basel). 2010;2(2):338–363. doi:10.3390/cancers2020338
  47. Slavin J. Why whole grains are protective: Biological mechanisms. Proc Nutr Soc. 2003;62(1):129–134. doi:10.1079/PNS2002221
  48. Arvola A, Lähteenmäki L, Dean M, et al. Consumers’ beliefs about whole and refined grain products in the UK, Italy and Finland. J Cereal Sci. 2007;46(3):197–206. doi:10.1016/j.jcs.2007.06.001
  49. Rosa NN, Dufour C, Lullien-Pellerin V, Micard V. Exposure or release of ferulic acid from wheat aleurone: Impact on its antioxidant capacity. Food Chem. 2013;141(3):2355–2362. doi:10.1016/j.foodchem.2013.04.132
  50. de Paula Dias Moreira L, Nery Enes VPB de SJ B, Celi Lopes Toledo R, et al. Chia (Salvia hispanica L.) flour and oil ameliorate metabolic disorders in the liver of rats fed a high-fat and high fructose diet. foods. 2022;11(3):285. doi:10.3390/foods11030285
  51. Baynes JW, Dominiczak MH. Medical Biochemistry. 4th ed. Elsevier Saunders; 2015;377.
  52. Gil MI, Tomás-Barberán FA, Hess-Pierce B, Kader AA. Antioxidant capacities, phenolic compounds, carotenoids, and vitamin C contents of nectarine, peach, and plum cultivars from California. J Agric Food Chem. 2002;50(17):4976–4982. doi:10.1021/jf020136b
  53. Singh M, Tonk RS. Management of salivary hypofunction. Pharm Anal Acta. 2015;6:2. doi:10.4172/2153-2435.1000331
  54. Xiao K, Liu C, Qin Q, et al. EPA and DHA attenuate deoxynivalenol-induced intestinal porcine epithelial cell injury and protect barrier function integrity by inhibiting necroptosis signaling pathway. FASEB J. 2020;34(2):2483–2496. doi:10.1096/fj.201902298R
  55. Enes BN, Moreira LPD, Silva BP, et al. Chia seed (Salvia hispanica L.) effects and their molecular mechanisms on unbalanced diet experimental studies: A systematic review. J Food Sci. 2020;85(2):226–239. doi:10.1111/1750-3841.15003
  56. Gumantara MPB, Oktarlina RZ. Perbandingan monoterapi dan kombinasi terapi sulfonilurea-metformin terhadap pasien diabetes melitus tipe 2. Majority. 2017;6(1):55–59. https://www.semanticscholar.org/paper/Perbandingan-Monoterapi-dan-Kombinasi-Terapi-Pasien-Gumantara-Oktarlina/a0feefc0d90d1697a49a94aba3bf2c3fa38ec9e3. Accessed February 1, 2017.
  57. Husna F, Suyatna FD, Arozal W, Purwaningsih EH. Model Hewan Coba pada Penelitian Diabetes. Pharm Sci Res. 2019;6(3):131–141. doi:10.7454/psr.v6i3.4531
  58. Keswani SG, Balaji S, Le LD, et al. Role of salivary vascular endothelial growth factor (VEGF) in palatal mucosal wound healing. Wound Repair Regen. 2013;21(4):554–562. doi:10.1111/wrr.12065
  59. Perrotti V, Piattelli A, Piccirilli M, Bianchi G, Di Guilio C, Artese L. Vascular endothelial growth factor expression (VEGF) in salivary glands of diabetic rats. Int J Immunopathol Pharmacol. 2007;20(1 Suppl 1):55–60. doi:10.1177/039463200702001s12
  60. Radwan IA, Rady D, Ramadan M, El Moshy S. Mechanism underlying the anti-diabetic potential of bee venom as compared to bone marrow mesenchymal stem cells in the diabetic rat tongue. Dent Med Probl. 2024;61(1):53–64. doi:10.17219/dmp/152924
  61. Desta T, Li J, Chino T, Graves DT. Altered fibroblast proliferation and apoptosis in diabetic gingival wounds. J Dent Res. 2010;89(6):609–614. doi:10.1177/0022034510362960
  62. Peplow PV, Baxter GD. Gene expression and release of growth factors during delayed wound healing: A review of studies in diabetic animals and possible combined laser phototherapy and growth factor treatment to enhance healing. Photomed Laser Surg. 2012;30(11):617–636. doi:10.1089/pho.2012.3312
  63. Neri M, Milazzo D, Ugolini D, et al. Worldwide interest in the comet assay: A bibliometric study. Mutagenesis. 2015;30(1):155–163. doi:10.1093/mutage/geu061
  64. Gajski G, Žegura B, Ladeira C, et al. The comet assay in animal models: From bugs to whales – (part 1 invertebrates). Mutat Res Rev Mutat Res. 2019;779:82–113. doi:10.1016/j.mrrev.2019.02.003
  65. Prawitasari DS. Diabetes melitus dan antioksidan. KELUWIH: Jurnal Kesehatan dan Kedokteran. 2019;1(1):47–51. doi:10.24123/kesdok.V1i1.2496
  66. Evans MD, Cooke MS. Factors contributing to the outcome of oxidative damage to nucleic acids. Bioessays. 2004;26(5):533–542. doi:10.1002/bies.20027
  67. Grancieri M, Martino HSD, de Mejia EG. Chia seed (Salvia hispanica L.) as a source of proteins and bioactive peptides with health benefits: A review. Compr Rev Food Sci Food Saf. 2019;18(2):480–499. doi:10.1111/1541-4337.12423
  68. Vuksan V, Jenkins AL, Brissette C, et al. Salba-chia (Salvia hispanica L.) in the treatment of overweight and obese patients with type 2 diabetes: A double-blind randomized controlled trial. Nutr Metab Cardiovasc Dis. 2017;27(2):138–146. doi:10.1016/j.numecd.2016.11.124